Oncology Information Systems to Drive Robustness in Care Delivery, Forecast to 2024

Oncology Information Systems to Drive Robustness in Care Delivery, Forecast to 2024

Future Growth Potential Lies in Precision Medicine and Cloud Adoption in Oncology Care

RELEASE DATE
01-Sep-2020
REGION
North America
Research Code: MF3F-01-00-00-00
SKU: HC03333-NA-MT_24699
$4,950.00
In stock
SKU
HC03333-NA-MT_24699
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

As cancer care becomes increasingly highly complex, the information, image data, and steps that comprise a single patient’s healthcare journey has grown tremendously. Oncology information systems (OIS) software are used by cancer clinics and departments, medical oncologists, radiation specialists, and department employees to manage and plan the treatment module of cancer patients. Automation of the oncology workflow with the EMR not only delivers greater department efficiency but can also help in improving the quality of care, reducing medical errors, decreasing clinical documentation time, providing rich data for clinical research, and controlling health costs. The software has evolved over the last decade as a tool to centralize the patient’s electronic medical record (EMR) in an easily accessible place and to manage the treatment process from referral to treatment and eventually disease management. The main market participants are Elekta and Varian that are also major radiation equipment manufacturers. Their large customer base in radiation centers and the integration capabilities that their software offers with their radiation equipment are major positives. Oncology has been a ripe space for healthcare IT systems in the recent past, and EHR companies such as Epic and Cerner have made a place for themselves with oncology-specific EHRs and data analytics capabilities. Data analytics and visualization tools have also gained importance with increasing sophistication of the disease. The global OIS market is driven by associated advantages of OIS over conventional record maintenance, and surge in prevalence of cancer worldwide. In addition, rise in awareness of the benefits of using OIS is expected to fuel the market growth. The adoption of OIS developed by software vendors will increase in the coming years as health systems and hospitals realize the value they bring in the maintenance of systems, regular updates, and training, as they focus solely on software development. Further, EHR and other software vendors will invest in R&D to develop stronger OIS solutions and focus on interoperability with current radiation equipment. Integration of oncology information systems into main hospital workflows, shift to the cloud, and increased usage of artificial intelligence (AI) in oncology information systems are slated to be growth opportunities for key market participants in the near future. Increased sophistication of OIS will take place as value-based rules come into the picture, patient engagement takes center stage, and telehealth becomes the new normal (post COVID-19). An OIS will have to encompass all the market dynamics to stay relevant to oncology practices around the world.

Author: Chandni Mathur

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Scope and Segmentation

Key Questions this Study will Answer

Market Engineering Measurements

CEO’s Perspective

Global Adoption of OIS and Key Vendors

Executive Summary—3 Big Predictions

Five Growth Opportunities Critical for Future Strategy

Market Overview and Definitions

Market Segmentation

Shift to Offering Cloud Based Oncology Software

OIS Vendors Pushing the Cloud Agenda

Incorporation of AI Tools into OIS

OIS and Key Healthcare Concepts

Value-based Care—A Key Driver for the Adoption of OIS

OIS—Advantage of Driving Precision Medicine in Oncology

Data Aggregated from a Comprehensive OIS—A Critical Component of a PHM Strategy

Vendor Ecosystem

Vendor Types and Strategies

Vendor Types and Strategies (Radiation Equipment Vendors + Other Med-tech companies)

Vendor Types and Strategies (EHR Vendors)

Vendor Types and Strategies (other Software Vendors)

Competitor Assessment

Elekta

Varian Medical Systems

RaySearch Laboratories

Epic Systems

Philips

Recent Notable Developments That Impact the OIS Market

Distribution Structure

Critical Success Factors

Market Drivers

Market Restraints

Plotting Impact of External Factors (Opportunities and Threats)

Revenue Calculation Model

Revenue Forecast Assumptions

Market Engineering Measurements

Revenue Forecast

Percent Revenue Forecast by Region

Revenue Forecast

Revenue Forecast

Market Share of Key Vendors

Current State of Adoption

Current State of Adoption—North America

Current State of Adoption—Europe

Current State of Adoption—APAC

Five Growth Opportunities Critical for Future Strategy

Growth Opportunity 1—Focus on Precision Medicine

Growth Opportunity 2—Incorporation of AI Algorithms

Growth Opportunity 3—Offering Interoperable Solutions

Growth Opportunity 4—Adoption of the Cloud

Growth Opportunity 5—Expanding into Cancer Care Coordination Solutions

Identifying Your Company’s Growth Zone

Growth Opportunities 1–5—Vision and Strategy

Growth Opportunities Matrix

Prioritized Opportunities through Implementation

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

Related Research
As cancer care becomes increasingly highly complex, the information, image data, and steps that comprise a single patients healthcare journey has grown tremendously. Oncology information systems (OIS) software are used by cancer clinics and departments, medical oncologists, radiation specialists, and department employees to manage and plan the treatment module of cancer patients. Automation of the oncology workflow with the EMR not only delivers greater department efficiency but can also help in improving the quality of care, reducing medical errors, decreasing clinical documentation time, providing rich data for clinical research, and controlling health costs. The software has evolved over the last decade as a tool to centralize the patients electronic medical record (EMR) in an easily accessible place and to manage the treatment process from referral to treatment and eventually disease management. The main market participants are Elekta and Varian that are also major radiation equipment manufacturers. Their large customer base in radiation centers and the integration capabilities that their software offers with their radiation equipment are major positives. Oncology has been a ripe space for healthcare IT systems in the recent past, and EHR companies such as Epic and Cerner have made a place for themselves with oncology-specific EHRs and data analytics capabilities. Data analytics and visualization tools have also gained importance with increasing sophistication of the disease. The global OIS market is driven by associated advantages of OIS over conventional record maintenance, and surge in prevalence of cancer worldwide. In addition, rise in awareness of the benefits of using OIS is expected to fuel the market growth. The adoption of OIS developed by software vendors will increase in the coming years as health systems and hospitals realize the value they bring in the maintenance of systems, regular updates, and training, as they focus solely on software development. Further, EHR and other software vendors will invest in R&D to develop stronger OIS solutions and focus on interoperability with current radiation equipment. Integration of oncology information systems into main hospital workflows, shift to the cloud, and increased usage of artificial intelligence (AI) in oncology information systems are slated to be growth opportunities for key market participants in the near future. Increased sophistication of OIS will take place as value-based rules come into the picture, patient engagement takes center stage, and telehealth becomes the new normal (post COVID-19). An OIS will have to encompass all the market dynamics to stay relevant to oncology practices around the world. Author: Chandni Mathur
More Information
No Index No
Podcast No
Author Chandni Mathur
Industries Healthcare
WIP Number MF3F-01-00-00-00
Is Prebook No
GPS Codes 9564-B1,9575-B1,9600-B1,9612-B1,99BC-B1